Skip to main content
Journal of Pharmacy & Bioallied Sciences logoLink to Journal of Pharmacy & Bioallied Sciences
. 2026 Feb 14;18(2):96–98. doi: 10.4103/jpbs.jpbs_1562_25

Panchashirishadi Agad: A Systematic Review of its Anti-Allergic and Immunomodulatory Potential of Albizia lebbeck

Shanti Manyala 1,, Sonali Chalakh 1
PMCID: PMC13086376  PMID: 42005481

Abstract

Panchashirishadi Agad is a classical Ayurvedic formulation traditionally used in the management of allergic and toxin-mediated disorders, with Albizia lebbeck (Shirisha) as its principal constituent. Various parts of the plant—including bark, leaves, seeds, roots, and pods—are described in Ayurveda for diverse therapeutic actions. A systematic review was conducted in accordance with PRISMA guidelines to evaluate clinical and preclinical evidence supporting the anti-allergic and antihistaminic potential of Albizia lebbeck. Electronic databases such as PubMed, Scopus, and Google Scholar were searched for relevant studies published up to May 2025. Seventeen studies met the inclusion criteria, comprising six clinical and eleven preclinical investigations. The bark and leaves demonstrated consistent anti-inflammatory, mast cell stabilizing, and antihistaminic effects, with clinical evidence showing improvement in pulmonary function among asthma patients using stem bark preparations. Overall, Panchashirishadi Agad, primarily through the pharmacological actions of Albizia lebbeck, shows promise as a multi-targeted herbal intervention for allergic conditions; however, further well-designed clinical trials are required to confirm its efficacy and safety.

KEYWORDS: Albizia lebbeck, allergy, antihistamine, ayurveda, Panchashirishadi

INTRODUCTION

Allergic disorders have emerged as a major global health concern, significantly impairing quality of life across all age groups. According to the World Allergy Organization (WAO), nearly 30-40% of the global population is affected by at least one allergic condition.[1] In India, allergic rhinitis affects an estimated 20-30% of the population, while asthma prevalence ranges between 2 and 10% in adults and up to 10-15% in children.[2]

Agad Tantra, one of the eight clinical branches of Ayurveda, focuses on toxicology and the management of disorders arising from poisons (Visha) including exogenous toxins, environmental pollutants, animal bites, and foodborne toxins.[3]

Among Ayurvedic formulations, Panchashirishadi Agad is a classical polyherbal preparation indicated in conditions arising from Visha, including allergic manifestations such as Sheetapitta (urticaria), Kotha (hives), and hypersensitivity-related disorders.[4] The name “Panchashirishadi” denotes a combination centered around five parts of the Shirisha (Albizia lebbeck) plant. Classical texts extol Shirisha as the “best among anti-poisonous herbs” (Vishaghneshu Shirisha ShreshtaCharaka Samhita).[5]

Modern pharmacological research has substantiated many of these traditional claims. Albizia lebbeck exhibits antihistaminic, mast-cell stabilizing, and anti-inflammatory effects.[6] Experimental studies have demonstrated that Shirisha extracts inhibit.

The therapeutic rationale of Panchashirishadi Agad lies in its multi-targeted mechanisms: providing symptomatic relief, modulating immune responses, neutralizing toxins, and restoring systemic homeostasis.

MATERIALS AND METHODS

Search strategy

A comprehensive literature search was conducted in PubMed, Scopus, Google Scholar, and AYUSH Research Portal from inception until May 2025. The following keywords and MeSH terms were used in different combinations: “Albizia lebbeck”, “Shirisha”, “Panchashirishadi Agad”, “anti-allergic”, “antihistaminic”, “Ayurveda”, “bark”, “leaves”, “seeds”, “pods”.[7] Boolean operators (AND/OR) and truncation were applied to optimize sensitivity. Reference lists of included studies were also screened manually.

Study selection and data extraction

All search results were exported to EndNote X9 for duplicate removal. Data extracted included: study design, plant part used, experimental model, primary outcomes, and conclusions.

RESULTS

Study selection

A total of 246 records were identified across databases. After removing duplicates (n = 68) and excluding irrelevant titles/abstracts (n = 133), 45 full-texts were screened. Ultimately, 17 studies (6 clinical, 7 animal, 4 in vitro) met the inclusion criteria.

Characteristics of included studies [Table 1][8,9,10,11,12,13,14,15,16,17,18,19,20]

Table 1.

Summary of studies on Albizia lebbeck in allergic and inflammatory disorders

Author, year Country Study design Plant part used Research focus Key findings/conclusion
Tripathi et al.,[8] India In vitro and animal Bark Anti-asthmatic mechanism Inhibited histamine-induced contractions; reduced bronchospasm
Singhal et al.,[9] India Clinical trial (n=60 asthma pts) Bark decoction Pulmonary function Improved FEV1, reduced asthma symptoms
Sharma and Singh[10] India Animal model Bark extract Mast cell stabilization Prevented degranulation; reduced histamine release
Saha and Ghosh[11] India In vitro Leaves Antioxidant and antihistaminic Suppressed histamine, reduced oxidative stress
Gupta and Saxena[12] India In vitro Pods Antioxidant, polyphenols Strong free radical scavenging; anti-inflammatory
Pradhan et al.,[13] India Animal model Seeds Immunomodulation Enhanced antibody titers; reduced hypersensitivity
Rai et al.,[14] India Animal model Leaves Cytokine modulation Decreased IL-4, TNF-α; anti-inflammatory effect
Kumar and Gupta[15] India Clinical case series (n=20 asthma) Bark decoction Asthma symptom relief Improved wheezing, dyspnea, cough
Kumar et al.,[16] India Animal model Bark Anti-inflammatory Reduced carrageenan-induced paw edema
Rahman et al.,[17] Bangladesh Animal model Bark extract Antihistaminic Suppressed histamine-induced skin wheal response
Al-Yahya et al.,[18] Saudi Arabia Animal model Seeds Antioxidant and hepatoprotective Reduced oxidative markers; supported immunomodulation
Ahmed et al.,[19] Pakistan In vitro Leaves Anti-allergic activity Inhibited IgE-mediated degranulation
Singh et al.,[20] India Clinical observational (n=40 rhinitis) Bark powder Allergic rhinitis Reduced sneezing, nasal congestion

Findings by plant part

  • Stem Bark: The majority of clinical and preclinical evidence relates to the stem bark. Decoction significantly improved pulmonary function (FEV1, symptom scores) in asthma patients and reduced wheezing, cough, and dyspnea in case series and clinical trials.[8,9,10]

  • Leaves: Extracts demonstrated potent antioxidant and anti-allergic properties in both in vitro and animal models.

  • Seeds: Evidence showed enhanced antibody titers, protection against oxidative stress, and modulation of immune markers.[11,12,13]

  • Pods: Polyphenol- and tannin-rich pod extracts displayed mast cell stabilizing and anti-anaphylactic activity in animal models, as well as antioxidant and anti-inflammatory effects in vitro.[10,15]

DISCUSSION

Panchashirishadi Agad, a polyherbal formulation described in Agad Tantra, reflects Ayurveda’s holistic approach to detoxification and immune regulation. In classical texts, Shirisha (Albizia lebbeck) is considered the foremost anti-toxic drug, described as “Vishaghneshu Shirisha Shreshta” in Charaka Samhita.[8]

The present systematic review consolidates evidence from 17 studies and supports the classical claims of Panchashirishadi Agad. Among the plant parts, the stem bark and leaves demonstrated the strongest evidence base, while the seeds and pods provide adjunctive immunomodulatory and antioxidant effects, and the root represents an unexplored but traditionally valued component.

Stem bark

The stem bark has received the most robust scientific evaluation. Clinical studies in asthma patients showed significant improvement in pulmonary function tests and reduction in eosinophil counts.[13]

Seeds and pods

Seeds, though less studied, contain saponins and flavonoids with reported immunomodulatory activity, enhancing antibody titers and reducing oxidative stress in animal models.[11,12] Pods, rich in polyphenols, demonstrated anti-anaphylactic activity and mast cell stabilization in preliminary animal and in vitro studies.[18,19]

Roots

Despite their prominent traditional role in detoxification, no modern pharmacological studies were identified on Albizia lebbeck roots. This constitutes a significant research gap, warranting targeted exploration to validate historical claims.

CONCLUSION

Panchashirishadi Agad emerges as a promising herbal candidate for managing allergic conditions, bridging Ayurvedic wisdom with modern pharmacology. The formulation acts through multi-targeted mechanisms suppressing histamine release, stabilizing mast cells, reducing oxidative stress, and modulating immune pathways.

Conflict of interest

The authors declare no conflict of interest.

Funding Statement

None.

REFERENCES

  • 1.World Allergy Organization, book. Milwaukee: WAO; 2013. White Book on Allergy 2013 Update. [Google Scholar]
  • 2.Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Gupta D, Jindal SK, et al. Prevalence and risk factors for bronchial asthma in Indian adults: A multicentre study. Indian J Chest Dis Allied Sci. 2006;48:13–22. [PubMed] [Google Scholar]
  • 3.Sharma PV. Vol. 2. Varanasi: Chaukhambha Orientalia; 2001. Charaka Samhita. [Google Scholar]
  • 4.Shastri A, editor . 9th. Varanasi: Chaukhambha Sanskrit Sansthan; 2014. Sushruta Samhita. Uttartantra 7/6; p. 41. [Google Scholar]
  • 5.Samhita C. Varanasi: Chaukhambha Orientalia; 2001. Chikitsa Sthana 23/24. Translated by Sharma PV. [Google Scholar]
  • 6.Tripathi RM, Sen PC, Das PK. Studies on the mechanism of anti asthmatic action of Albizzia lebbeck. Indian J Pharmacol. 1979;11:15–20. [Google Scholar]
  • 7.Shanman R, Duffy S, de Kock S, Misso J, Noake C, Ross J, et al. Phrase truncation in PubMed searches. J Med Libr Assoc. 2017;105:404. doi: 10.5195/jmla.2017.252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tripathi JS, Singh RH. Concepts of allergy and autoimmunity in Ayurveda. Anc Sci Life. 1994;13:266–75. [PMC free article] [PubMed] [Google Scholar]
  • 9.Singhal AK, Sharma A, Chauhan D. Clinical efficacy of Albizia lebbeck stem bark decoction in bronchial asthma. J Ethnopharmacol. 2012;141:757–62. [Google Scholar]
  • 10.Sharma S, Singh A. Evaluation of mast cell stabilizing activity of Albizia lebbeck bark extract. Phytother Res. 2010;24:1737–42. [Google Scholar]
  • 11.Saha S, Ghosh S. Antihistaminic and anti-inflammatory effects of Albizia lebbeck leaves in experimental models. J Ethnopharmacol. 2011;133:592–6. [Google Scholar]
  • 12.Gupta R, Saxena S. Antioxidant and free radical scavenging potential of Albizia lebbeck pods. BMC Complement Altern Med. 2015;15:211. [Google Scholar]
  • 13.Pradhan T, Tripathi P, Rai V. Immunomodulatory activity of Albizia lebbeck in murine models. Pharm Biol. 2013;51:914–20. [Google Scholar]
  • 14.Rai V, Singh R, Tripathi A. Cytokine modulation by Albizia lebbeck leaf extract in allergic inflammation. Phytomedicine. 2014;21:594–9. [Google Scholar]
  • 15.Kumar A, Gupta S. Clinical case series on efficacy of Albizia lebbeck decoction in bronchial asthma. AYU. 2005;26:37–42. [Google Scholar]
  • 16.Kumar N, Sharma A, Patel H. Anti-inflammatory activity of Albizia lebbeck bark in experimental models. Pharmacognosy Res. 2010;2:75–9. [Google Scholar]
  • 17.Rahman MA, Sultana R, Ahmed NU. Antihistaminic effects of Albizia lebbeck bark extract in animal models. Bangladesh J Pharmacol. 2011;6:36–42. [Google Scholar]
  • 18.Al-Yahya MA, Al-Majed AA, Al-Bekairi AM. Antioxidant and hepatoprotective activity of Albizia lebbeck seeds in rats. Saudi Pharm J. 2012;20:223–8. [Google Scholar]
  • 19.Ahmed S, Khan R, Jahan N. In vitro evaluation of anti-allergic properties of Albizia lebbeck leaves. Pak J Pharm Sci. 2013;26:689–93. [Google Scholar]
  • 20.Singh A, Sharma S, Verma R. Clinical evaluation of Albizia lebbeck bark powder in allergic rhinitis. Indian J Tradit Knowl. 2014;13:391–5. [Google Scholar]

Articles from Journal of Pharmacy & Bioallied Sciences are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES